REFERENCES
- Abu-Dahab R., Schafer U. F., Lehr C. M. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur. J. Pharm. Sci. 2001; 14(1)37–46
- Anderson J. M., Shive M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 1997; 28: 5–24
- Bandi N., Kompella U. B. Budesonide reduces vascular endothelial growth factor (VEGF) secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur. J. Pharmacol. 2001; 425(2)109–16
- Brown R. A., Schanker L. S. Absorption of aerosolized drugs from the rat lung. Drug Metab. Distrib. 1983; 11: 355–360
- Goldstein I. J., Hayes C. E. The lectins: carbohydrate-binding proteins of plants and animals. Adv. Carbohydr. Chem. Biochem. 1978; 35: 127–340
- Konduri K. S., et al. Efficacy of liposomal budesonide in experimental asthma. J. Allergy Clin. Immunol. 2003; 111: 321–327
- Lai Y. L., et al. Sustained bronchodilation with soproterenol poly(glycolide-co-lactide) microspheres. Pharm. Res. 1993; 10: 119–125
- Lehr C. M. Lectin–mediated drug delivery: the second generation of bioadhesives. J. Control. Rel. 2000; 65(1–2)19–29
- Mo Y., Lim L. Y. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J. Pharmaceu. Sci. 2004; 93: 20–28
- Naazneen S., et al. Assessment of in-vitro antiproliferative activity after intracellular drug delivery from wheat germ agglutinin-conjugated budesonide nanoparticles. J. Biomed. Nanotechnol. 2007; 3: 61–67
- Sahoo S. K., Panyam J., Prabha S., Labhasetwar V. Residual polyvinyl alcohol associated with poly (lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Rel. 2002; 82(1)105–114
- Suarez S., et al. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J. Antimicrob. Chemother. 2001; 48: 431–434
- Wirth M., et al. Lectin-mediated drug targeting: preparation, binding characteristics and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm. Res. 1998; 15: 1031–1037